Carisoprodol Tablet
Product Images NDC 62135-241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 62135-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carisoprodol-tablets-120-label (Carisoprodol Tablets Label)

Carisoprodol-tablets-120-label (Carisoprodol Tablets Label)
Carisoprodol Tablets, USP 350 mg oral tablets packaging label by Chartwell RX, LLC. The label states Rx Only and a quantity of 120 tablets. It includes dosage and storage instructions, a barcode, and notes the product is made in the USA with no varnish on the label surface.*
FDA Label Image

Carisoprodol-structure (Carisoprodol Tablets Structure)

Carisoprodol-structure (Carisoprodol Tablets Structure)
Chemical structure diagram of Carisoprodol, illustrating its molecular framework with labeled groups including amide, ester, and isopropyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.